ACCENDRA HEALTH INC/VA/ — Form 8-K
Filed November 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
On October 29, 2026, Accendra Health amended its Receivables Purchase Agreement to extend the Scheduled Termination Date from its prior date to October 2029. The facility size remains unchanged at $150 million. CFO Jonathan Leon stated the extension demonstrates the strength of the company's accounts receivable portfolio and banking partnership.
Why this rating
Routine facility extension; $150M is ~22% of market cap but extension is administrative renewal, not new capital or material operational change.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.